BIG
PRCT icon

Brooklyn Investment Group’s Procept Biorobotics PRCT Stock Holding History

Brooklyn Investment Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.06M Buy
+42,388
New +$1.19M 0.03% 529
2025
Q3 		– Sell
-92
Closed -$5.3K – 2158
2025
Q2 		$5.3K Buy
92
+89
+2,967% +$5.03K ﹤0.01% 2443
2025
Q1 		$175 Buy
+3
New +$205 ﹤0.01% 2647

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Brooklyn Investment Group's PRCT Position: Q1 2026 in Review

Brooklyn Investment Group opened a new position in Procept Biorobotics (PRCT) in Q1 2026: 42,388 shares worth $1.06M. The stake represents 0.03% of the portfolio and ranks #529 among its holdings. This is a return to the name: Brooklyn Investment Group previously reported a position in PRCT as recently as Q2 2025.

Brooklyn Investment Group first reported a position in PRCT in Q1 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Brooklyn Investment Group held 42,388 shares of Procept Biorobotics worth $1.06M as of Q1 2026.
  • Procept Biorobotics was a new Brooklyn Investment Group position in Q1 2026.
  • Procept Biorobotics made up 0.03% of Brooklyn Investment Group's portfolio in Q1 2026, its #529 holding.
  • Brooklyn Investment Group first reported a position in Procept Biorobotics in Q1 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.